University of the District of Columbia - Management Letter Report for Year Ended September 30, 2012 Read more about University of the District of Columbia - Management Letter Report for Year Ended September 30, 2012
Executive Summary Concerning an Investigation into Misconduct Violations by Employees of the DC Office of the Chief Financial Officer Read more about Executive Summary Concerning an Investigation into Misconduct Violations by Employees of the DC Office of the Chief Financial Officer
Application Control Review of the Integrated Tax System Read more about Application Control Review of the Integrated Tax System
Report of Special Evaluation: Department of Human Services New York Avenue Men's Emergency Shelter Read more about Report of Special Evaluation: Department of Human Services New York Avenue Men's Emergency Shelter
DC Unemployment Compensation Fund - Management Letter Report - Years Ended September 30, 2012, and 2011 Read more about DC Unemployment Compensation Fund - Management Letter Report - Years Ended September 30, 2012, and 2011
Home Purchase Assistance Program (Special Revenue Fund) - Financial Statements for the Fiscal Year Ended September 30, 2012 (With Independent Auditors' Report Thereon) Read more about Home Purchase Assistance Program (Special Revenue Fund) - Financial Statements for the Fiscal Year Ended September 30, 2012 (With Independent Auditors' Report Thereon)
Office of the Inspector General's Response to the April 17, 2013 Letter of Inquiry from Councilmember Kenyan McDuffie Read more about Office of the Inspector General's Response to the April 17, 2013 Letter of Inquiry from Councilmember Kenyan McDuffie
Drug Manufacturer Amgen Agrees to Pay Medicaid Program Over $14.7 Million to Resolve Illegal Kickback Case Read more about Drug Manufacturer Amgen Agrees to Pay Medicaid Program Over $14.7 Million to Resolve Illegal Kickback Case Drug Manufacturer Amgen Agrees to Pay Medicaid Program Over $14.7 Million to Resolve Illegal Kickback Case
PAR Pharmaceuticals to Pay $22.5 Million in Settlement Read more about PAR Pharmaceuticals to Pay $22.5 Million in Settlement PAR Pharmaceuticals to Pay $22.5 Million in Settlement
Testimony Before the Committee on Government Operations - Fiscal Year 2014 Budget Review Read more about Testimony Before the Committee on Government Operations - Fiscal Year 2014 Budget Review Testimony Before the Committee on Government Operations - Fiscal Year 2014 Budget Review